汉典生物启动北交所IPO：董事长专科学历，总经理曾在大学任教

Company Overview - Jiangsu Handian Biotechnology Co., Ltd. (referred to as Handian Bio) has completed its IPO counseling filing with the Jiangsu Securities Regulatory Bureau and plans to list on the Beijing Stock Exchange, with Nanjing Securities as the counseling institution [2] - Handian Bio was established in 2010 with a registered capital of 107 million yuan, focusing on nutritional foods, sports nutrition foods, and health foods [2] Management Structure - The actual controllers of the company are Yang Jianqing and Ding Xiangdong, who collectively hold 60.75% of the shares, with Yang Jianqing serving as the chairman and Ding Xiangdong as the director and general manager [2] - As of December 31, 2024, Yang Jianqing and Ding Xiangdong hold 42.06% and 18.69% of the company's shares, respectively [2] Management Background - Yang Jianqing, born in May 1964, is a Chinese national with permanent residency in the United States and has a specialized education background. He has held various positions in the electronics and biotechnology sectors since 1986 [2] - Ding Xiangdong, born in November 1963, has a bachelor's degree and has extensive experience in teaching and management within the pharmaceutical and health food industries since 1985 [4] Financial Performance - In 2024, the company's revenue increased by 79.63% to 382 million yuan, while the net profit attributable to shareholders of the listed company surged by 168.81% to 65.4487 million yuan [5]